Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) FCF Margin (2022 - 2023)

Unicycive Therapeutics filings provide 2 years of FCF Margin readings, the most recent being 580.74% for Q1 2023.

  • On a quarterly basis, FCF Margin changed N/A to 580.74% in Q1 2023 year-over-year; TTM through Dec 2023 was 2708.59%, a N/A change, with the full-year FY2023 number at 2710.37%, down 106442.0% from a year prior.
  • FCF Margin hit 580.74% in Q1 2023 for Unicycive Therapeutics, down from 374.66% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 374.66% in Q3 2022 to a low of 580.74% in Q1 2023.